Wagar, Lisa E. http://orcid.org/0000-0001-5980-3586
Salahudeen, Ameen
Constantz, Christian M.
Wendel, Ben S. http://orcid.org/0000-0001-6896-3354
Lyons, Michael M.
Mallajosyula, Vamsee
Jatt, Lauren P. http://orcid.org/0000-0001-7034-9046
Adamska, Julia Z.
Blum, Lisa K. http://orcid.org/0000-0002-7921-8939
Gupta, Neha
Jackson, Katherine J. L. http://orcid.org/0000-0002-9952-7069
Yang, Fan http://orcid.org/0000-0003-4821-6583
Röltgen, Katharina
Roskin, Krishna M.
Blaine, Kelly M.
Meister, Kara D.
Ahmad, Iram N.
Cortese, Mario
Dora, Emery G.
Tucker, Sean N.
Sperling, Anne I.
Jain, Aarti
Davies, D. Huw
Felgner, Philip L.
Hammer, Gregory B.
Kim, Peter S. http://orcid.org/0000-0001-6503-4541
Robinson, William H.
Boyd, Scott D. http://orcid.org/0000-0003-0963-044X
Kuo, Calvin J. http://orcid.org/0000-0002-7427-5985
Davis, Mark M. http://orcid.org/0000-0001-6868-657X
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (5U19AI05722915, 1R01AI130398, U54CA224081, U19AI116484, U01CA217851, U01DK085527)
Howard Hughes Medical Institute (N/A)
Bill and Melinda Gates Foundation
Article History
Received: 12 March 2020
Accepted: 27 October 2020
First Online: 11 January 2021
Competing interests
: S.N.T., M.C. and E.G.D. are employed and have stock options with the biotechnology company Vaxart. P.L.F. and D.H.D. have shares in Nanommune, a company that uses Sino Biological’s proteins on commercially available protein microarrays. L.E.W., A.S., C.M.C., B.S.W., M.M.L., V.M., L.P.J., J.Z.A., L.K.B., N.G., K.J.L.J., F.Y., K.R., K.M.R., K.M.B., K.D.M., I.N.A., A.I.S., A.J., G.B.H., P.S.K., W.H.R., S.D.B., C.J.K. and M.M.D. declare no competing interests.
Free to read: This content has been made available to all.